Xylose

Xylose

SCHEMBL27858332

Nc1ccn([C@@H]2O[C@H](CO)[C@@H](OP(=O)(O)O)[C@H]2O)c(=O)n1.O=CC(O)C(O)C(O)CO

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
THRB P10828 1/20 0.54
MTOR P42345 1/20 0.54
MDM2 Q00987 1/20 0.54
NCOA1 Q15788 1/20 0.54
NCOA3 Q9Y6Q9 1/20 0.54
NT5E P21589 1/20 0.47
P2RY2 P41231 1/20 0.43
PDE4D Q08499 1/20 0.43
PDE3A Q14432 1/20 0.43
SLC29A1 Q99808 1/20 0.43
ST6GAL1 P15907 4/20 0.42
TSHR P16473 1/20 0.41
GLA P06280 1/20 0.41
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Xylose SCHEMBL27858293 0.93 LMNA (0.54) LMNATHRBMTORMDM2NCOA1
SCHEMBL2212574 0.88 LMNA (0.69) LMNATHRBMTORMDM2NCOA1
SCHEMBL79966 0.88 LMNA (0.69) LMNATHRBMTORMDM2NCOA1
SCHEMBL10177274 0.88 LMNA (0.69) LMNATHRBMTORMDM2NCOA1
SCHEMBL4735554 0.88 LMNA (0.69) LMNATHRBMTORMDM2NCOA1
SCHEMBL3608348 0.88 LMNA (0.69) LMNATHRBMTORMDM2NCOA1
SCHEMBL18151989 0.88 LMNA (0.69) LMNATHRBMTORMDM2NCOA1
SCHEMBL11617377 0.88 LMNA (0.69) LMNATHRBMTORMDM2NCOA1
Cytarabine 5'-Phosphate SCHEMBL27855304 0.87 P2RY2 (0.55) LMNATHRBMTORMDM2NCOA1
Cytidine SCHEMBL21381483 0.87 LMNA (0.72) LMNATHRBMTORMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104857526-B The method for treating eye disease 夸克制药公司 2019-03-05 CN disclosed
CN-102458418-B Pharmaceutical application of oligonucleotide compound QUARK PHARMACEUTICALS, INC. (US) 2015-09-16 CN disclosed
CN-102458418-A Method for treating chronic kidney disease QUARK PHARMACEUTICALS INC 2012-05-16 CN disclosed
CN-102026670-A Novel siRNA compounds for inhibition of RTP801 QUARK PHARMACEUTICALS INC 2011-04-20 CN disclosed